Reply to the Letter to the Editor: "It is urgent to evaluate the efficacy and safety of genotype guided antiplatelet therapy in patients after percutaneous coronary intervention in East Asian"

Int J Cardiol. 2022 Feb 1:348:57. doi: 10.1016/j.ijcard.2021.11.069. Epub 2021 Dec 9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cytochrome P-450 CYP2C19 / genetics
  • Genotype
  • Humans
  • Percutaneous Coronary Intervention* / adverse effects
  • Platelet Aggregation Inhibitors* / adverse effects

Substances

  • Platelet Aggregation Inhibitors
  • Cytochrome P-450 CYP2C19